STOCK TITAN

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Centessa Pharmaceuticals (Nasdaq: CNTA) has announced its participation in two upcoming investor conferences. The first event is the Jefferies London Healthcare Conference on November 17, 2022, featuring a fireside chat at 10:55 AM GMT. The second is the Evercore ISI HealthCONx Conference, held virtually on November 30, 2022, at 3:30 PM ET.

Live webcasts and archived recordings will be accessible on the Centessa Pharmaceuticals investor relations website.

Positive
  • None.
Negative
  • None.

BOSTON and LONDON, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that members of its management team will participate in the following investor conferences:

Event: Jefferies London Healthcare Conference
Date: Thursday, November 17, 2022
Location: London, UK
Fireside Chat: 10:55 AM GMT

Event: Evercore ISI HealthCONx Conference (Virtual)
Date: Wednesday, November 30, 2022
Fireside Chat: 3:30 PM ET

Access to the live webcasts of these events, as well as archived recordings, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/events-presentations.

About Centessa Pharmaceuticals 
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications in rare diseases and immuno-oncology. We operate with the conviction that each one of our programs has the potential to change the current treatment paradigm and establish a new standard of care. For more information, visit www.centessa.com, which does not form part of this release. 

Contact:
Kristen K. Sheppard, Esq.
SVP of Investor Relations
investors@centessa.com


FAQ

What events will Centessa Pharmaceuticals participate in during November 2022?

Centessa Pharmaceuticals will participate in the Jefferies London Healthcare Conference on November 17, 2022, and the Evercore ISI HealthCONx Conference on November 30, 2022.

When is the fireside chat for the Jefferies London Healthcare Conference?

The fireside chat for the Jefferies London Healthcare Conference will take place at 10:55 AM GMT on November 17, 2022.

What time is the Evercore ISI HealthCONx Conference fireside chat?

The fireside chat for the Evercore ISI HealthCONx Conference is scheduled for 3:30 PM ET on November 30, 2022.

Where can I access the webcasts for Centessa Pharmaceuticals' conferences?

Webcasts for Centessa Pharmaceuticals' conferences can be accessed under the 'Events and Publications' tab on their investor relations website.

What is the main focus of Centessa Pharmaceuticals?

Centessa Pharmaceuticals is focused on discovering and developing transformative medicines, particularly in rare diseases and immuno-oncology.

Centessa Pharmaceuticals plc American Depositary Shares

NASDAQ:CNTA

CNTA Rankings

CNTA Latest News

CNTA Stock Data

2.30B
114.15M
1.32%
92.52%
1.85%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
ALTRINCHAM, CHESHIRE